- STAT+: Amylyx nears pivotal endocrine drug study readoutAmylyx Pharmaceuticals will soon read out results from a study evaluating a new treatment for a rare endocrine disorder, a pivotal moment for patients and the company.STAT · 11d ago↗ source
- Opinion: The growing fang-to-pharmacy pipeline“Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of creatures we’ve been taught to fear,” writes Steve Midway.STAT · 11d ago↗ source
- Opinion: Medicaid and SNAP cuts are exacerbating the intertwined problems of hunger and mental illness“No one built a psychiatric unit to solve hunger,” writes clinical dietician Cole Hanson. But patients come anyway.STAT · 11d ago